Transcriptome analysis of bone marrow mesenchymal stromal cells from patients with primary myelofibrosis.

Archive ouverte

Martinaud, Christophe | Desterke, Christophe | Konopacki, Johanna | Vannucchi, Alessandro M | Pieri, Lisa | Guglielmelli, Paola | Dupriez, Brigitte | Ianotto, Jean-Christophe | Boutin, Laetitia | Lataillade, Jean-Jacques | Le Bousse-Kerdilès, Marie-Caroline

Edité par CCSD ; Elsevier -

International audience. Primary myelofibrosis (PMF) is a clonal myeloproliferative neoplasm whose severity and treatment complexity are attributed to the presence of bone marrow (BM) fibrosis and alterations of stroma impairing the production of normal blood cells. Despite the recently discovered mutations including the JAK2V617F mutation in about half of patients, the primitive event responsible for the clonal proliferation is still unknown. In the highly inflammatory context of PMF, the presence of fibrosis associated with a neoangiogenesis and an osteosclerosis concomitant to the myeloproliferation and to the increase number of circulating hematopoietic progenitors suggests that the crosstalk between hematopoietic and stromal cells is deregulated in the PMF BM microenvironmental niches. Within these niches, mesenchymal stromal cells (BM-MSC) play a hematopoietic supportive role in the production of growth factors and extracellular matrix which regulate the proliferation, differentiation, adhesion and migration of hematopoietic stem/progenitor cells. A transcriptome analysis of BM-MSC in PMF patients will help to characterize their molecular alterations and to understand their involvement in the hematopoietic stem/progenitor cell deregulation that features PMF.

Consulter en ligne

Suggestions

Du même auteur

Osteogenic Potential of Mesenchymal Stromal Cells Contributes to Primary Myelofibrosis.

Archive ouverte | Martinaud, Christophe | CCSD

International audience. Primary myelofibrosis is a myeloproliferative neoplasm that is a precursor to myeloid leukemia. Dysmegakaryopoiesis and extramedullary hematopoiesis characterize primary myelofibrosis, which ...

Macrophage-derived oncostatin M contributes to human and mouse neurogenic heterotopic ossifications

Archive ouverte | Torossian, Frédéric | CCSD

International audience

V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis.

Archive ouverte | Campbell, Peter J | CCSD

International audience. Most patients with polycythemia vera and half with idiopathic myelofibrosis and essential thrombocythemia have an acquired V617F mutation in JAK2. Using sensitive polymerase chain reaction (P...

Chargement des enrichissements...